HCPCS drug code · CMS crosswalk
Docetaxel J-Code / HCPCS Code
In short
CMS assigns Docetaxel NDCs to 2 HCPCS codes: J9171 (per 1 mg), J9232 (per 1 mg). Which one applies depends on the product; the table lists each NDC with its code.
Reference
- J9171
- Injection, docetaxel, 1 mgBilling unit: 1 mg
- J9232
- Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mgBilling unit: 1 mg
- Labelers
- Accord Healthcare Inc; Actavis Pharma, Inc.; Alembic Pharmaceuticals Inc.; Amneal Pharmaceuticals, LLC; Baxter Healthcare Corp.; Baxter Healthcare Corporation; Eugia US LLC; Heritage Pharmaceuticals Inc.and 7 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Docetaxel units and claim line
Enter the dose given to get the J9171 units and the NDC line for the CMS-1500 and the 837P. This builds the J9171 line; use the code page for J9232.
Enter the dose given to build the claim line.
Docetaxel NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00143-9204-01 | J9171 | Hikma Pharmaceuticals USA Inc. | 1 | 20 |
| 00143-9205-01 | J9171 | Hikma Pharmaceuticals USA Inc. | 4 | 80 |
| 00955-1020-01 | J9171 | Sanofi-Aventis U.S. LLC | 1 | 20 |
| 00955-1021-04 | J9171 | Sanofi-Aventis U.S. LLC | 4 | 80 |
| 00955-1022-08 | J9171 | Sanofi-Aventis U.S. LLC | 8 | 160 |
| 16729-0267-65 | J9171 | Accord Healthcare Inc | 8 | 160 |
| 23155-0903-31 | J9171 | Heritage Pharmaceuticals Inc. | 1 | 20 |
| 23155-0904-31 | J9171 | Heritage Pharmaceuticals Inc. | 4 | 80 |
| 23155-0905-31 | J9171 | Heritage Pharmaceuticals Inc. | 8 | 160 |
| 25021-0245-01 | J9171 | Sagent Pharmaceuticals | 1 | 20 |
| 25021-0245-04 | J9171 | Sagent Pharmaceuticals | 4 | 80 |
| 43066-0046-08 | J9171 | Baxter Healthcare Corp. | 8 | 80 |
| 43066-0048-16 | J9171 | Baxter Healthcare Corp. | 16 | 160 |
| 45963-0734-54 | J9171 | Actavis Pharma, Inc. | 1 | 20 |
| 45963-0765-52 | J9171 | Actavis Pharma, Inc. | 4 | 80 |
| 55150-0379-01 | J9171 | Eugia US LLC | 8 | 80 |
| 55150-0380-01 | J9171 | Eugia US LLC | 16 | 160 |
| 67457-0781-08 | J9171 | Mylan Institutional LLC | 8 | 160 |
| 70121-1221-01 | J9171 | Amneal Pharmaceuticals, LLC | 1 | 20 |
| 70121-1222-01 | J9171 | Amneal Pharmaceuticals, LLC | 4 | 80 |
| 70121-1223-01 | J9171 | Amneal Pharmaceuticals, LLC | 8 | 160 |
| 00409-0016-01 | J9232 | Pfizer Inc | 16 | 160 |
| 00409-0201-02 | J9232 | Pfizer Inc | 2 | 20 |
| 00409-0201-10 | J9232 | Pfizer Inc | 8 | 80 |
| 00409-0201-20 | J9232 | Pfizer Inc | 16 | 160 |
| 00409-0365-01 | J9232 | Pfizer Inc | 8 | 160 |
| 00409-0366-01 | J9232 | Pfizer Inc | 1 | 20 |
| 00409-0367-01 | J9232 | Pfizer Inc | 4 | 80 |
| 00409-0368-01 | J9232 | Pfizer Inc | 8 | 160 |
| 00409-1732-01 | J9232 | Pfizer Inc | 16 | 160 |
| 00409-2026-01 | J9232 | Pfizer Inc | 2 | 20 |
| 00409-4235-01 | J9232 | Pfizer Inc | 1 | 20 |
| 00409-5068-01 | J9232 | Pfizer Inc | 4 | 80 |
| 00409-7870-01 | J9232 | Pfizer Inc | 8 | 80 |
| 25021-0254-08 | J9232 | Sagent Pharmaceuticals | 8 | 80 |
| 25021-0254-16 | J9232 | Sagent Pharmaceuticals | 16 | 160 |
| 43066-0001-01 | J9232 | Baxter Healthcare Corporation | 2 | 20 |
| 43066-0006-01 | J9232 | Baxter Healthcare Corporation | 8 | 80 |
| 43066-0010-01 | J9232 | Baxter Healthcare Corporation | 16 | 160 |
| 43066-0044-02 | J9232 | Baxter Healthcare Corporation | 2 | 20 |
| 62332-0678-02 | J9232 | Alembic Pharmaceuticals Inc. | 2 | 20 |
| 62332-0678-08 | J9232 | Alembic Pharmaceuticals Inc. | 8 | 80 |
| 62332-0678-16 | J9232 | Alembic Pharmaceuticals Inc. | 16 | 160 |
| 66758-0050-01 | J9232 | Sandoz Inc. | 2 | 20 |
| 66758-0050-02 | J9232 | Sandoz Inc. | 8 | 80 |
| 66758-0050-03 | J9232 | Sandoz Inc. | 16 | 160 |
| 67457-0531-02 | J9232 | Mylan Institutional LLC | 2 | 20 |
| 67457-0532-08 | J9232 | Mylan Institutional LLC | 8 | 80 |
| 67457-0533-16 | J9232 | Mylan Institutional LLC | 16 | 160 |
| 71288-0144-08 | J9232 | Meitheal Pharmaceuticals Inc. | 8 | 80 |
| 71288-0144-16 | J9232 | Meitheal Pharmaceuticals Inc. | 16 | 160 |
| 72078-0040-08 | J9232 | Mylan Institutional LLC | 8 | 80 |
Docetaxel: common questions
- What is the J-code for Docetaxel?
- CMS assigns Docetaxel NDCs to 2 HCPCS codes: J9171 (per 1 mg), J9232 (per 1 mg). Which one applies depends on the product; the table lists each NDC with its code.
- How many J9171 billing units are in a package of Docetaxel?
- CMS lists 20 to 160 billing units per package, depending on the NDC, where one unit is 1 mg. Units to report are based on the dose given, not the package.
- How many J9232 billing units are in a package of Docetaxel?
- CMS lists 20 to 160 billing units per package, depending on the NDC, where one unit is 1 mg. Units to report are based on the dose given, not the package.
- Is J9171 a CPT code?
- No. J9171 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.